Source link : https://www.newshealth.biz/health-news/real-world-car-t-cell-therapy-outcomes-favorable-in-relapsed-refractory-myeloma/
Real-world outcomes of patients with relapsed/refractory multiple myeloma treated with the chimeric antigen receptor (CAR) T-cell therapy ciltacabtagene autoleucel (cilta-cel, Carvykti) showed “favorable” efficacy results, even though many of them would not have been eligible for the trial that led to the drug’s approval, according to a retrospective study. Among patients who received cilta-cel infusions […]
Author : News Health
Publish date : 2024-10-04 21:35:22
Copyright for syndicated content belongs to the linked Source.
Categories